
Few diseases pose as many diagnostic challenges as ovarian cancer. Unlike other gynecologic cancers, in which patients can present with tell-tale conditions while the disease is still at an early stage, two-thirds of ovarian cancer cases are advanced when first detected. Identifying postsurgical recurrence is also difficult. According to several studies presented at the 2005 RSNA meeting, PET/CT may have an important role to play in detecting and evaluating this silent killer.









